Zobrazeno 1 - 9
of 9
pro vyhledávání: '"T V, Strong"'
Autor:
F, Wang-Johanning, A R, Frost, G L, Johanning, M B, Khazaeli, A F, LoBuglio, D R, Shaw, T V, Strong
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(6)
We investigated the expression of human endogenous retroviral (HERV) sequences in breast cancer.Reverse transcription-PCR (RT-PCR) was used to examine expression of the envelope (env) region of ERV3, HERV-E4-1, and HERV-K in breast cancer cell lines,
Autor:
R D, Alvarez, M N, Barnes, J, Gomez-Navarro, M, Wang, T V, Strong, W, Arafat, R B, Arani, M R, Johnson, B L, Roberts, G P, Siegal, D T, Curiel
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(8)
The purpose of this Phase I study was to determine the feasibility of using an anti-erbB-2-encoding adenovirus (Ad21) to treat erbB-2-overexpressing ovarian cancer. Recurrent ovarian cancer patients were treated i.p. with Ad21 in dosages ranging from
Autor:
K, Kasono, J L, Blackwell, J T, Douglas, I, Dmitriev, T V, Strong, P, Reynolds, D A, Kropf, W R, Carroll, G E, Peters, R P, Bucy, D T, Curiel, V, Krasnykh
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(9)
In vivo cancer gene therapy approaches for squamous cell carcinoma of the head and neck (SCCHN) based on adenoviral vector-mediated gene delivery have been limited by the suboptimal efficacy of gene transfer to tumor cells. We hypothesized that this
Autor:
R M, Conry, S A, White, P N, Fultz, M B, Khazaeli, T V, Strong, K O, Allen, D L, Barlow, S E, Moore, P N, Coan, I, Davis, D T, Curiel, A F, LoBuglio
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 4(11)
In preparation for a Phase I trial of DNA immunization against carcinoembryonic antigen (CEA) in patients with colorectal carcinoma, we have produced a single plasmid DNA encoding CEA and hepatitis B surface antigen (HBsAg) under transcriptional regu
Autor:
W E, Highsmith, L H, Burch, Z, Zhou, J C, Olsen, T V, Strong, T, Smith, K J, Friedman, L M, Silverman, R C, Boucher, F S, Collins, M R, Knowles
Publikováno v:
Human mutation. 9(4)
A splicing mutation was identified at the +5 position of the splice donor site of exon 14b of CFTR in CF patients in a consanguineous family that is remarkable for unusually mild disease. Quantitative studies of nasal epithelial mRNA revealed that ho
Publikováno v:
Gene therapy. 3(11)
Previous work by this group has established that E1-defective, recombinant adenoviruses can be replication-enabled by the codelivery of a plasmid encoding the deleted E1 functions, a strategy now designated conditional replication-enablement system f
Publikováno v:
Human mutation. 7(2)
Publikováno v:
Human molecular genetics. 3(11)
Publikováno v:
Oncogene. 6(6)
The v-fms encoded kinase, which is known to associate with cytoskeletal elements, was shown to phosphorylate histiocytic proteins that had physical and immunological attributes in common with tau. Tau is a microtubule associated protein that is aberr